Floatz logo

FLAVONE, 3,3',4',5,7-PENTAHYDROXY-

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Al-Mustansiriyah UniversitySmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

65 Active assets in the PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries cohort.

Asset / SponsorPhaseRating
Semaglutide
Methodist Health System
Phase 4BBB
Hcg
Eman Basuni Ebrahim Mowad
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
FOLLITROPIN BETA
Universitair Ziekenhuis Brussel
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB

View all 50 →

Same molecule, other indications

FLAVONE, 3,3',4',5,7-PENTAHYDROXY- is also rated in:

Myeloma MultipleDormant
BBB
Indicative ·
72 / 100
View asset →
Hepatitis B Virus InfectionDormant
BB
Indicative ·
69 / 100
View asset →
Fanconi anemiaDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →